{"disease":{"id":"immunodeficiency-virus-human","name":"immunodeficiency virus human"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06368453","title":"A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test","phase":"NA","overall_status":"COMPLETED","enrollment_count":1728,"lead_sponsor_name":"bioLytical Laboratories","has_results":false},{"nct_id":"NCT02431247","title":"A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":725,"lead_sponsor_name":"Janssen Sciences Ireland UC","has_results":true},{"nct_id":"NCT03984552","title":"Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children","phase":"","overall_status":"UNKNOWN","enrollment_count":502,"lead_sponsor_name":"The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)","has_results":false},{"nct_id":"NCT06651957","title":"Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)","phase":"","overall_status":"COMPLETED","enrollment_count":217,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05413811","title":"Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02696824","title":"Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa","phase":"NA","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT05619497","title":"The OPENS Trial: Offering Women PrEP (Aim 2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07061912","title":"A Study to Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended Users in the US","phase":"NA","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"bioLytical Laboratories","has_results":false},{"nct_id":"NCT06519994","title":"Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02479698","title":"Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06253533","title":"ICVAX as a HIV Therapeutic DNA Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Immuno Cure Holding (HK) Limited","has_results":false},{"nct_id":"NCT01976715","title":"Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00798265","title":"A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT07530198","title":"HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":22,"lead_sponsor_name":"Immuno Cure Holding (HK) Limited","has_results":false},{"nct_id":"NCT05261191","title":"A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"MacroGenics","has_results":true},{"nct_id":"NCT03783130","title":"Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT05700734","title":"MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}